Patients diagnosed with diabetes in the context of acute COVID-19 were more likely to be prescribed insulin with 91 days of diagnosis (52/420, 12%, compared with 11/166, 7%, for controls) but there was no clear evidence of an increase in type 1 DM at any stage of the illness (S6 Text). The gene discussed is INS; the disease is COVID-19.